myBiometry
Boston, US · 4 known investors
MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.
Founders & leadership
BN
Bryan NolanFounder
Investors · 4
Frequently asked questions
- What does myBiometry do?
- MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.
- Who founded myBiometry?
- myBiometry was founded by Bryan Nolan.
- Who are myBiometry's investors?
- myBiometry's investors include Bantam Group, Boston Harbor Angels, Elevate Ventures, Launchpad Venture Group.
- Where is myBiometry headquartered?
- myBiometry is headquartered in Boston, US.